James Kuo

Dr. James (Jim) Kuo currently serves as Chief Executive Officer of Return Health and Managing Director of Athena Bioventures in La Jolla, CA. He is an experienced biotech industry executive and investor, who brings financial and management experience to the company. During his career, he has held executive positions in private as well as listed bioscience companies in the US, Canada, and Europe. He previously served as CEO of Tryp Therapeutics, Synthetic Biologics, BioMicro Systems, and Discovery Laboratories. Prior to that, Dr. Kuo was Associate Director in Corporate Licensing and Development at Pfizer and Managing Director of HealthCare Ventures, a $378 million venture fund. He received his MD from the University of Pennsylvania School of Medicine and his MBA from the Wharton School of Business. Dr. Kuo's undergraduate education is in molecular biology and music history from Haverford College.